WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Sunday, March 18, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email

Thyroid Cancer Markets Forecasts Report 2018-2028 - Focus on 21 Major Markets with Key Comorbid Conditions / Features Associated With the Disease
Friday, January 12, 2018

DUBLIN, Jan. 12, 2018 /PRNewswire/ --

The "Thyroid Cancer Forecast in 21 Major Markets 2018-2028" report has been added to's offering.

Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer, but the most common of the endocrine system. The main clinical split is between differentiated and undifferentiated tumour types, with the majority being well-differentiated.

This report provides the current incident population for thyroid cancer across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Saudi Arabia, South Africa, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current incidence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several features of thyroid cancer patients, as well as the main symptoms and comorbidities of the disease have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of thyroid cancer include:

    --  Familial Adenomatous Polyposis
    --  Acromegaly
    --  Diabetes
    --  Multiple endocrine neoplasia syndromes

    --  Sipple syndrome

Key Topics Covered:

    1. Introduction
    2. Cause of the Disease
    3. Risk Factors & Prevention
    4. Diagnosis of the Disease
    5. Variation by Geography/Ethnicity
    6. Disease Prognosis & Clinical Course
    7. Key Comorbid Conditions / Features Associated With the Disease
    8. Methodology for Quantification of Patient Numbers
    9. Additional Data Available on Request
    10. Top-Line Incidence for Thyroid Cancer
    11. Features of Thyroid Cancer Patients
    12. Papillary Thyroid Cancer Patients
    13. Comorbidities of Thyroid Cancer Patients
    14. Abbreviations Used in the Report
    15. Other Services & Solutions
    16. Reports & Publications
    17. Online Epidemiology Databases
    18. Online Pharmaceutical Pricing Database
    19. References

    20. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Xilinx Technology Enables 5G for Hyper-Connected Urban Society at University of Bristol Smart Internet Lab | Mar 17, 2018
Nav P4 Gains Broad Networking Industry Adoption, Joins Open Networking Foundation (ONF) and Linux Foundation (LF) to Accelerate Next Phase of Growth and Innovation | Mar 16, 2018
Nav Software Asset Management Market Worth 2.32 Billion USD by 2022 | Mar 16, 2018
Nav 2018 Global Cyber Security Market Report 2013-2023 - Rising Incidence of Cyber Attacks & Usage of Mobile Devices is Driving the Market | Mar 16, 2018
Nav Artificial Intelligence in Healthcare Market 52.68% CAGR Growth Report by 2022 | Mar 16, 2018
Nav Global Pharma, Biotech and Diagnostics Co-development Partnering Terms and Agreements Directory 2012-2018 | Mar 16, 2018
Nav ProfNet Experts Available on St. Patrick's Day, Solo Travel, More | Mar 16, 2018
Nav ATCorp Set to Release CYRIN - the Next Generation Online Cyber Security Training Platform | Mar 16, 2018
Nav ABC Financial and FitMetrix Announce Vendor Relationship | Mar 16, 2018
Nav UL Warns of Potentially Hazardous Direct Replacement LED Tube Lamps (Release 17PN-23) | Mar 16, 2018

Submit News | View More News View More News